Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which sedation drug is safer for mom and baby during C-Section?

NCT ID NCT07676955

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study compares two medications—dexmedetomidine and low-dose ketamine—given as a single dose before a planned C-section under spinal anesthesia. Both groups then receive a steady infusion of dexmedetomidine to keep them comfortable. Researchers will measure how well each drug sedates the mother, her blood pressure and heart rate, satisfaction scores, and the baby's health right after birth. The goal is to find which approach offers better comfort with fewer side effects for both mother and newborn.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dexmedetomidine and ketamine
What this could lead to
If one drug proves better, it could improve comfort and safety for mothers undergoing planned C-sections.
What could go wrong
This is a small, early-phase trial (80 people) comparing two existing drugs, so results may not apply broadly or show major differences.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

80 people

The number who actually took part.

Started

Jun 2021

Finished

Dec 2021

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * American Society of Anesthesiologists (ASA) physical classification status I patients * aged \>18 years scheduled for cesarean/section surgery under spinal anesthesia were enrolled to the study Exclusion Criteria: * known sensitivity or allergy to study drugs * a history of analgesic or narcotic abuse * any contraindications for spinal anesthesia * emergency cesarean/section * existing of fetal distress.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarean birth are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sultangazi Haseki Training and Research Hospital

    Istanbul, Sultangazi, 34265, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.